| Systematic (IUPAC) name | |
|---|---|
| (4R,5S,6S)-3-(6,7-dihydro-5H- pyrazolo[1,2-a][1,2,4]triazol-8- ium-6-ylsulfanyl)- 6-(1-hydroxyethyl)- 4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | IV |
| Identifiers | |
| CAS number | 120410-24-4 |
| ATC code | J01DH05 |
| PubChem | CID 71339 |
| ChemSpider | 64442 |
| UNII | YR5U3L9ZH1 |
| ChEBI | CHEBI:3089 |
| ChEMBL | CHEMBL285347 |
| Chemical data | |
| Formula | C15H18N4O4S |
| Mol. mass | 350.39 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Biapenem (INN) is a carbapenem antibiotic. It has in vitro activity against anaerobes.[1]
Approved in Japan in 2001.
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)